117 related articles for article (PubMed ID: 31291025)
1. VEGFR-2 is downregulated in sestamibi-negative parathyroid adenomas.
Erovic BM; Goldstein DP; Asa SL; Janik S; Mete O; Irish JC
Head Neck; 2019 Oct; 41(10):3564-3569. PubMed ID: 31291025
[TBL] [Abstract][Full Text] [Related]
2. Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas.
Bleier BS; LiVolsi VA; Chalian AA; Gimotty PA; Botbyl JD; Weber RS
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):779-82. PubMed ID: 16847189
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.
Kao A; Shiau YC; Tsai SC; Wang JJ; Ho ST
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1012-5. PubMed ID: 12173014
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.
Casas AT; Burke GJ; Sathyanarayana ; Mansberger AR; Wei JP
Am J Surg; 1993 Oct; 166(4):369-73. PubMed ID: 8214295
[TBL] [Abstract][Full Text] [Related]
5. Preoperative detection of sporadic parathyroid adenomas using technetium-99m-sestamibi: what role in clinical practice?
Carter WB; Sarfati MR; Fox KA; Patton DD
Am Surg; 1997 Apr; 63(4):317-21. PubMed ID: 9124749
[TBL] [Abstract][Full Text] [Related]
6. Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and
Kushchayeva YS; Tella SH; Kushchayev SV; Van Nostrand D; Kulkarni K
Osteoporos Int; 2019 May; 30(5):1051-1057. PubMed ID: 30706095
[TBL] [Abstract][Full Text] [Related]
7. The sestamibi scan as a preoperative screening tool.
Norton KS; Johnson LW; Griffen FD; Burke J; Kennedy S; Aultman D; Li BD; Zibari G
Am Surg; 2002 Sep; 68(9):812-5. PubMed ID: 12356156
[TBL] [Abstract][Full Text] [Related]
8. Preoperative localization of parathyroid adenomas: ultrasonography, sestamibi scintigraphy, or both?
Hajioff D; Iyngkaran T; Panagamuwa C; Hill D; Stearns MP
Clin Otolaryngol Allied Sci; 2004 Oct; 29(5):549-52. PubMed ID: 15373872
[TBL] [Abstract][Full Text] [Related]
9. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings.
Sun SS; Shiau YC; Lin CC; Kao A; Lee CC
Nucl Med Biol; 2001 Nov; 28(8):929-33. PubMed ID: 11711312
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic utility of dual phase Tc-99m sestamibi parathyroid imaging.
Klieger P; O'Mara R
Clin Nucl Med; 1998 Apr; 23(4):208-11. PubMed ID: 9554190
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of surgeon interpretation of technetium tc 99m sestamibi scans in localizing parathyroid adenomas.
Anderson SR; Vaughn A; Karakla D; Wadsworth JT
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):953-7. PubMed ID: 18794440
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability.
Bhatnagar A; Vezza PR; Bryan JA; Atkins FB; Ziessman HA
J Nucl Med; 1998 Sep; 39(9):1617-20. PubMed ID: 9744355
[TBL] [Abstract][Full Text] [Related]
14. The Sestamibi Paradox: Improving Intraoperative Localization of Parathyroid Adenomas.
Buicko JL; Kichler KM; Amundson JR; Scurci S; Kozol RA
Am Surg; 2017 Aug; 83(8):832-835. PubMed ID: 28822386
[TBL] [Abstract][Full Text] [Related]
15. Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue.
Mehta NY; Ruda JM; Kapadia S; Boyer PJ; Hollenbeak CS; Stack BC
Arch Otolaryngol Head Neck Surg; 2005 Jun; 131(6):493-8. PubMed ID: 15967881
[TBL] [Abstract][Full Text] [Related]
16. The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings.
Merlino JI; Ko K; Minotti A; McHenry CR
Am Surg; 2003 Mar; 69(3):225-9; discussion 229-30. PubMed ID: 12678479
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging.
Takeuchi H; Greep NC; Hoon DS; Giuliano AE; Hansen NM; Umetani N; Singer FR
J Clin Endocrinol Metab; 2007 May; 92(5):1785-90. PubMed ID: 17299072
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy.
Haber RS; Kim CK; Inabnet WB
Clin Endocrinol (Oxf); 2002 Aug; 57(2):241-9. PubMed ID: 12153604
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
Billy HT; Rimkus DR; Hartzman S; Latimer RG
Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
[TBL] [Abstract][Full Text] [Related]
20. A novel technique to improve the diagnostic yield of negative sestamibi scans.
Nagar S; Walker DD; Embia O; Kaplan EL; Grogan RH; Angelos P
Surgery; 2014 Sep; 156(3):584-90. PubMed ID: 24931283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
